Signaling pathways
-
BA5641 U-69593Summary: U-69593 is an effective and selective agonist. -
BA5642 CCG258747Summary: CCG258747 is a selective inhibitor (=18nM) with high selectivity for GRK1, GRK5, PKA and (518, 83, >5500 and >550-fold, respectively).
-
BA5643 BPR1M97Summary: BPR1M97 is a dual-acting agonist at mu opioid receptors and nociceptin orphan morphine FQ peptide receptors.
-
BA5644 KNT-127Summary: KNT-127 is a potent and selective opioid receptor agonist effective by systemic administration.
-
BA5645 LY2795050Summary: LY2795050 is a short-acting selective KOR antagonist.
-
BA5647 BevenopranSummary: A peripheral mu opioid receptor antagonist.
-
BA5648 LY255582Summary: LY255582 is a pan-opioid antagonist.
-
BA5649 NaltrexoneSummary: Naltrexone is an antagonist. -
BA5650 LY2444296Summary: LY2444296 is an orally bioactive, high affinity, selective, short-acting antagonist.
-
BA5651 J-113397Summary: The first potent and selective nonpeptidyl antagonist.